Glycoprotein transmembrane nmb: An androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells

Prostate

Volumn 72, Issue 13, 2012, Pages 1431-1442

  Tsui, Ke Hung ^a,b   Chang, Ying Ling ^b   Feng, Tsui Hsia ^b   Chang, Phei Lang ^a,b   Juang, Horng Heng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

androgen; GPNMB; maspin; Ndrg1; p53; prostate; PSA

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANGIOGENESIS INHIBITOR; COMPLEMENTARY DNA; DOXORUBICIN; GLYCOPROTEIN TRANSMEMBRANE NMB; MASPIN; MATRIGEL; MEMBRANE PROTEIN; METRIBOLONE; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; UNCLASSIFIED DRUG;

ANDROGEN THERAPY; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL STRAIN LNCAP; DOWN REGULATION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; N MYC DOWNSTREAM REGULATED GENE 1; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; METRIBOLONE; MICE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; TESTOSTERONE CONGENERS;

EID: 84864878865     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22494     Document Type: Article

References (42)

1. Safadi FF, Xu J, Smock SI, Rico MC, Owen TA, Popoff SN,. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 2002; 84: 12-26.
2. Bandari PS, Qian J, Yehia G, Joshi DD, Maloof PB, Potian J, Oh HS, Gascon P, Harrison JS, Rameshwar P,. Hematopoietic growth factor inducible neurokinin-1 type: A transmembrane protein that is similar to neruokinin 1 interacts with substance P. Regul Pept 2003; 111: 169-178. (Pubitemid 36254765)
3. Shikano S, Bonkobara M, Zukas PK, Ariizumi K,. Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans. J Biol Chem 2001; 276: 8125-8134.
4. Weterman MA, Ajubi N, van Dinter IM, Degen WG, van Muijen GN, Ruitter DJ, Bloemers HP,. nmb, a novel gene, is expressed in the low metastatic human melanoma cells lines and xenografts. Int J Cancer 1995; 60: 73-81.
5. Owen TA, Smock SL, Prakash S, Pinder L, Brees D, Krull D, Castleberry TA, Clancy YC, Marks SC, Safadi FF, Popoff SN,. Identification and characterization of the genes encoding human and mouse osteoactivin. Crit Rev Eukaryot Gene Expr 2003; 13: 205-220. (Pubitemid 38009170)
6. Sheng MHC, Wergedal JE, Mohan S, Lau KHW,. Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity. FEBS Lett 2008; 582: 1451-1458.
7. Metz RL, Yehia G, Fernandes H, Donnelly RJ, Rameshwar P,. Cloning and characterization of the 5' flanking region of the HGFIN gene indicate a cooperative role among p53 and cytokine-mediated transcription factors: Relevance to cell cycle regulation. Cell Cycle 2005; 4: 315-322. (Pubitemid 41365341)
8. Ghilardi C, Chiorino G, Dossi R, Nagy Z, Giavazzi R, Bani M,. Identification of novel vascular markers through gene expression profiling to tumor-derived endothelium. BMC Genomics 2008; 9: 201.
9. Loging WT, Lal A, Siu IM, Loney TL, Wikstrand CJ, Marra MA, Prange C, Bigner DD, Strausberg RL, Riggins GJ,. Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res 2000; 10: 1393-1402.
10. Ahn JH, Lee Y, Jeon CJ, Lee SJ, Kee B-H, Choi KD, Bae YS,. Identification of the gene differentially expressed in human dendritic cells subset by cDNA subtraction and microarray analysis. Blood 2002; 100: 1742-1754. (Pubitemid 34925153)
11. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M,. Molecular characterization of soft tissue tumours: A gene expression study. Lancet 2002; 359: 1301-1307. (Pubitemid 34310636)
12. Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan C-T, Bigner DD, Counter CM, Wang XF,. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 2003; 278: 15951-15957. (Pubitemid 36799713)
13. Borczuk AC, Gorenstein L, Walter AK, Assaad AA, Wang L, Powell CA,. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 2003; 163: 1949-1960. (Pubitemid 37310025)
14. Haralanova-Ilieva B, Ramadori G, Armbrust T,. Expression of osteoactivin in rat and human liver and isolated rat liver cells. J Hepatol 2005; 42: 565-572. (Pubitemid 40342937)
15. Onaga M, Ido A, Hasuike S, Uto H, Moriuchi A, Nagata K, Hori T, Hayash K, Tsubouchi H,. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J Hepatol 2003; 39: 779-785. (Pubitemid 37372188)
16. Rose AAN, Pepin F, Russo C, Khalil JEA, Hallett M, Siegel PM,. Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res 2007; 5: 1001-1014. (Pubitemid 350070756)
17. Metz RL, Patel PS, Hameed M, Bryan M, Rameshwar P,. Role of human HGFIN/nmb in breast cancer. Breast Cancer Res 2007; 9: R58.
18. Pang S-T, Dillner K, Wu X, Pousette A, Norstedt G, Flores-Morales A,. Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves gene related to oxidative stress. Endocrinology 2002; 143: 4897-4906. (Pubitemid 35397629)
19. Jiang F, Wang Z,. Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology 2003; 144: 1257-1265. (Pubitemid 36428467)
20. Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH,. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Prostate 2008; 68: 610-619.
21. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH,. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Mol Nutr Food Res 2011; 55: 1666-1676.
22. Tsui KH, Lin YF, Chen YH, Chang PL, Juang HH,. Mechanisms by which interleukin-6 regulates prostate specific antigen gene expression in prostate LNCaP carcinoma cells. J Androl 2011; 32: 383-393.
23. Tsui KH, Feng TH, Lin YF, Chang PL, Juang HH,. p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. Prostate 2011; 71: 62-70.
24. Tsui KH, Chang PL, Feng TH, Chung LC, Hsu SY, Juang HH,. Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells. Anticancer Res 2008; 28: 1977-1984.
25. Tsui KH, Chang PL, Feng TH, Chung LC, Sung HC, Juang HH,. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis. Anticancer Res 2008; 28: 1993-2000.
26. Juang HH, Lin Y-F, Chang P, Tsui KH,. Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor. J Urol 2010; 184: 2158-2164.
27. Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH,. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells. Int J Cancer 2011; DOI: 10.1002/ijc.26284.
28. Pang ST, Hsieh WC, Chuang CK, Chao CH, Weng WH,. Juang HH Thioredoxin-interacting protein: An oxidative stress-related gene is upregulated by glucose in human carcinoma cells. J Mol Endocrinol 2009; 42: 205-214.
29. Weijerman PC, Konig JJ, Wong ST, Niesters HG, Peehl DM,. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 1994; 54: 5579-5583. (Pubitemid 24346250)
30. Selim AA,. Osteoactivin bioinformatics analysis: Prediction of novel functions, structural features, and modes of action. Med Sci Monit 2009; 15: MT19-MT33.
31. White A, Lamb PW, Barrett JC,. Frequent downregulation of KAI1(CD82) metastasis suppressor protein in human cancer cell line. Oncogene 1998; 16: 3143-3149. (Pubitemid 28318785)
32. Rowe A, Weiske J, Kramer TS, Huber O, Jackson P,. Phorbol ester enhances KAI1 transcription by recruiting Tip60/Pontin complexes. Neoplasia 2008; 10: 1421-1432.
33. Furochi H, Tamura S, Mameoka M, Yamada C, Ogawa T, Hirasaka K, Okumura Y, Imagawa T, Oguri S, Ishidoh K, Kishi K, Higashiyama S, Nikawa T,. Osteoactivin fragments produced by ectodomain shedding induce MMP3 expression via ERK pathway in mouse NIH-3T3 fibroblasts. FEBS Lett 2007; 581: 5743-5750. (Pubitemid 350235424)
34. Tu LC, Yan X, Hood L, Lin B,. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics 2007; 6: 575-588. (Pubitemid 46630091)
35. Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM, Bremner WJ, Gleave ME, Nelson PS,. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer. Cancer Res 2007; 67: 5033-5041. (Pubitemid 46910214)
36. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K,. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 2003; 63: 1731-1736. (Pubitemid 36460828)
37. Li X, Chen D, Ying S, Meng Y, Yang H, Landis-Piwowar KR, Li Y, Sarkar FH, Reddy GP, Dou QP, Sheng S,. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. J Cell Physiol 2007; 212: 298-306. (Pubitemid 47025618)
38. Cher ML, Biliran HR, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, Sheng S,. Maspin expression inhibits oesteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. PNAS 2003; 100: 7847-7852. (Pubitemid 36760058)
39. Watanabe M, Nasu Y, Kashiwakura Y, Kusumi N, Tamayose K, Nagai A, Sasano T, Shimada T, Daida H, Kumon H,. Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: Long-term maspin expression efficiently suppresses tumor growth. Hum Gene Ther 2005; 16: 699-710. (Pubitemid 40864270)
40. Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS,. Maspin reduces prostate cancer metastasis to bone. Urol Oncol 2008; 26: 652-658.
41. Ripoll VM, Meadows NA, Raggatt LJ, Chang MK, Pettit AR, Cassady AI, Hume DA,. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB. Gene 2008; 413: 32-41.
42. Tsui KH, Chang PL, Lin HT, Juang HH,. Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells. J Urol 2004; 172: 2035-2039.